After Northland Securities and Cantor Fitzgerald gave Heron Therapeutics (NASDAQ: HRTX) a Buy rating last month, the company received another Buy, this time ...
The post Heron Therapeutics (HRTX) Received its Third Buy in a Row appeared first on Smarter Analyst.
After Northland Securities and Cantor...

https://www.smarteranalyst.com/new-blurbs/heron-therapeutics-hrtx-received-its-third-buy-in-a-row-15/

#SmarterAnalyst